Announced today by GSK: VHIO joins five other international research centers of excellence as member of the Oncology Clinical and Translational Consortium (OCTC)

• GSK undertakes global consortium incorporating six prestigious cancer research centers

• The Oncology Clinical and Translational Consortium (OCTC) includes centers in the US, Canada, France, the Netherlands and Spain

• Projects will focus on oncology clinical trials including combination therapies, as well as translational research

For more information and to access GSK´s press release issued today please see ´Related´ below.

Related Posts

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.